Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Erlotinib
Australian Public Assessment Report
Device/Product Name
Tarceva
Active ingredients
Erlotinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2009-00835-3-4
Submission Type
Extension of indications